Estrella Immunopharma Warrant
ESLAW
9 hedge funds and large institutions have $354K invested in Estrella Immunopharma Warrant in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.
44% more capital invested
Capital invested by funds: $245K → $354K (+$109K)
8.52% less ownership
Funds ownership: 32.18% → 23.66% (-8.5%)
25% less funds holding
Funds holding: 12 → 9 (-3)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RSWM
Robertson Stephens Wealth Management
San Francisco,
California
|
+$2.69K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$1.47K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$728 |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$113 |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$67 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BFM
1
Boothbay Fund Management
New York
| $296K | – | – | – |
|
|
RSWM
2
Robertson Stephens Wealth Management
San Francisco,
California
| $40.6K | +$2.69K | +26,000 | New |
|
|
SIA
3
SkyView Investment Advisors
Shrewsbury,
New Jersey
| $5K | – | – | – |
|
4
D.E. Shaw & Co
New York
| $4.38K | – | – | – |
|
|
YCM
5
Yakira Capital Management
Westport,
Connecticut
| $2.33K | – | – | – |
|
|
WA
6
Whitebox Advisors
Minneapolis,
Minnesota
| $2.12K | – | – | – |
|
|
CS
7
Clear Street
New York
| $1.7K | – | – | – |
|
|
8
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $1.08K | -$1.47K | -14,180 | -40% |
|
|
LCM
9
Landscape Capital Management
Englewood,
New Jersey
| $684 | – | – | – |
|
|
10
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$728 | -13,997 | Closed |
|
|
WAM
11
Wolverine Asset Management
Chicago,
Illinois
| – | -$113 | -2,191 | Closed |
|
|
12
UBS Group
Zurich,
Switzerland
| – | -$67 | -1,285 | Closed |
|
ESLAW Hedge Fund Activity: Q4 2025 in Review
9 of the 8,229 institutional investors tracked by Wall St. Rank reported a position in Estrella Immunopharma Warrant (ESLAW) for Q4 2025, worth a combined $354K — up 44% from $245K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ESLAW and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was Robertson Stephens Wealth Management, opening a new position worth an estimated $2.69K. The largest seller was Toronto Dominion Bank, cutting an estimated $1.47K.
- 9 institutional investors held Estrella Immunopharma Warrant (ESLAW) as of Q4 2025, down from 12 in Q3 2025.
- Funds reported $354K of Estrella Immunopharma Warrant stock for Q4 2025, up 44% quarter-over-quarter.
- 1 fund opened new Estrella Immunopharma Warrant positions in Q4 2025 and 3 closed out, a net change of -2 holders.
- The largest Estrella Immunopharma Warrant buyer in Q4 2025 was Robertson Stephens Wealth Management, an estimated $2.69K added.
- The largest Estrella Immunopharma Warrant seller in Q4 2025 was Toronto Dominion Bank, an estimated $1.47K sold.
Based on aggregated 13F filings for Q4 2025.